Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ADC Therapeutics (ADCT) Amortization - Intangibles (2019 - 2023)

ADC Therapeutics has reported Amortization - Intangibles over the past 5 years, most recently at $52.0 for Q3 2023.

  • Quarterly results put Amortization - Intangibles at $52.0 for Q3 2023, up 67.74% from a year ago — trailing twelve months through Sep 2023 was $185.0 (up 52.89% YoY), and the annual figure for FY2022 was $118.0, down 8.53%.
  • Amortization - Intangibles reached $52.0 in Q3 2023 per ADCT's latest filing, up from $51.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $9000.0 in Q1 2020 and bottomed at -$8983.0 in Q2 2020.
  • Median Amortization - Intangibles over the past 5 years was $31.0 (2022), compared with a mean of $27.41.
  • The largest annual shift saw Amortization - Intangibles skyrocketed 650.0% in 2020 before it crashed 99.72% in 2021.
  • Over 5 years, Amortization - Intangibles stood at $19.0 in 2019, then changed by 0.0% to $19.0 in 2020, then soared by 73.68% to $33.0 in 2021, then decreased by 9.09% to $30.0 in 2022, then skyrocketed by 73.33% to $52.0 in 2023.
  • Business Quant data shows Amortization - Intangibles for ADCT at $52.0 in Q3 2023, $51.0 in Q2 2023, and $52.0 in Q1 2023.